- CA$624.42m
- CA$873.25m
- CA$393.51m
- 66
- 44
- 96
- 77
C2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 186 | 180 | 340 | 325 | 394 |
Cost of Revenue | |||||
Gross Profit | 70.3 | 71 | 111 | 138 | 174 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 189 | 177 | 313 | 275 | 339 |
Operating Profit | -3.24 | 2.81 | 26.1 | 49.1 | 54.6 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -13.2 | -2.85 | 20 | 40.2 | 40.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | -7.04 | -2.39 | 21.8 | 28.3 | 31.5 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -7.49 | -3.5 | 20.4 | 26.4 | 30.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -7.49 | -3.5 | 20.4 | 26.4 | 30.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.133 | -0.076 | 0.333 | 0.376 | 0.51 |
Dividends per Share | |||||
Special Dividends per Share |